Dr. Elezaby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Stanford Healthcare
Palo Alto, CA 94305- Is this information wrong?
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2019 - 2023
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2017 - 2019
- Boston University School of MedicineClass of 2017, MD PhD
Certifications & Licensure
- CA State Medical License 2018 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 20 citationsCardiovascular effects of immunosuppression agents.Aly Elezaby, Ryan Dexheimer, Karim Sallam
Frontiers in Cardiovascular Medicine. 2022-01-01 - 50 citationsMitochondrial remodeling in mice with cardiomyocyte-specific lipid overloadAly Elezaby, Aaron L. Sverdlov, Vivian H. Tu, Kanupriya Soni, Ivan Luptak
Journal of Molecular and Cellular Cardiology. 2015-02-01 - 6 citationsA Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury.Nir Qvit, Amanda J Lin, Aly Elezaby, Nicolai P Ostberg, Juliane C Campos
Pharmaceuticals. 2022-02-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: